Similarly, TNFR2 agonism with STAR2 was also beneficial in a model of graft-versus-host disease [40], whereas NEWSTAR2 was recently shown to ameliorate neuropathology in a model of Alzheimer’s disease [41]. Here, TNFRSF1B is linked to early-onset autosomal dominant Alzheimer disease.